Kanishka Chakraborty, MD / Patient Care | Quillen ETSU Physicians | Regional Cancer Center
Assistant Professor | Division of Hematology/Oncology
Academice Office: Carl A. Jones, Building 1
Contact: 423.439.6362 | firstname.lastname@example.org
Kanishka Chakraborty, MD is Assistant Professor of Medicine at East Tennessee State University’s Quillen College of Medicine in Johnson City. After earning his medical degree from his native India, Dr. Chakraborty completed his residency in Internal Medicine and his fellowship in Medical Oncology at East Tennessee State University. During his post-graduate training, he was honored with the designation of Chief Resident and subsequently Chief Fellow.
Board certified both in Internal Medicine and Medical Oncology, Dr. Chakraborty serves on the faculty of the Department of Internal Medicine’s Division of Hematology/Oncology. His research interests include further assessing the role of tocotrienols in pancreatic cancer cells in order to explore their potential use as an adjunct to cancer treatment. In 2012, Dr. Chakraborty received the Paul E. Perlman Award for Research Excellence from Quillen College’s Department of Internal Medicine.
In his role as a clinician, Dr. Chakraborty received the 2009 David Daigneault Award from the Department of Internal Medicine, which honors a medicine resident with “outstanding clinical skills who demonstrates superior humanistic qualities, compassion, and empathy for patients.” He was subsequently recognized twice by the Department of Internal Medicine for providing exceptional patient care.
Dr. Chakraborty has published several articles in peer-reviewed journals, including the Journal of Oncology Pharmacy Practice and Free Radical Biology and Medicine. He has served as a reviewer for the American Journal of Hospice and Palliative Medicine and the Journal of Supportive Oncology. Dr. Chakraborty also won the 2012 Gold Scholarship from the New England Journal of Medicine for his essay exploring how the Internet and social networking can be harnessed to improve health.
Dr. Chakraborty is a member of the American College of Physicians, American Medical Association, American Society of Clinical Oncology, American Society of Hematology, and the American Association of Cancer Research.
-Outstanding fellow award from East Tennessee State University for cancer research work in the annual meeting of Tennessee Oncology Practice Society in 09/2012
-Paul E Perlman award for research excellence from the department of Internal Medicine, Quillen College of Medicine, East Tennessee State University in the annual graduation ceremony for 2011-2012
-Gold Scholarship by NEJM for winning the extremely prestigious essay contest in celebration of 200th year of publication of NEJM (New England Journal of Medicine) in June, 2012
'The David Daigneault' Award in 2009 during Internal Medicine residency for outstanding clinical skills, superior humanistic qualities, compassion and empathy for patients.
Assessing pleiotropic role of Tocotrienols in proliferation and apoptotic pathways in pancreatic cancer cells in order t0 explore future use in clinical trial as an adjunct to treatment or for prevention.
Exploring innovative ways to bring quality cancer care available to outreach areas across Southern Appalachian and underdeveloped part of the world.
1.Gamma-tocotrienol upregulates the ceramide transporter, Arv-1, in pancreatic cancer cells, accepted for poster presentation at American Association of Cancer Research Annual Meeting in 2013.
2. "Better health owes it to social networking" winner of New England Journal of Medicine (NEJM) essay contest for celebration of 200th year of publication of NEJM medical journal scheduled in June, 2012 in Boston, MA.
3. Successful Treatment of Nilotinib-induced Pleural Effusion with Prednisone; Journal of Oncology Pharmacy Practice; accepted in March, 2012.
4. Free Radic Biol Med. 2011 Sep 15; 51(6):1164-74. Epub 2011 Jun 21.Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.
5. South Med J. 2009 Sep; 102(9):977-8. A bone to pick about chest pain
6. A Rare Lung Cancer with Good Outcome. Society of General Internal Medicine, February 2011
7. Pathways to Induce Growth Arrest in Pancreatic Cancer Cell Lines by Downregulation of Her-2/ErbB2 Receptors. Presentation at 102nd meeting of the American Association of Cancer Research, April 2-6, 2011, Orlando, FL
8. Differential effects of Pravastatin and Simvastatin on the Growth of Tumor Cells from Different Organ Sites; PLoS One. 2011;6(12):e28813. Epub 2011 Dec 22.